About the Cancer Xenografts Session
Cancer xenografts are a cornerstone of cancer research, involving the transplantation of human tumor cells into immunodeficient mice. This model allows scientists to study tumor growth, progression, and response to treatments in a controlled environment that closely mimics human physiology. By implanting human cancer cells into mice, researchers can observe how tumors develop, metastasize, and interact with the host immune system. Furthermore, xenograft models enable the testing of potential therapies, such as chemotherapy drugs or immunotherapies, providing valuable insights into their efficacy and potential side effects before clinical trials in humans. Despite their limitations, such as the lack of a functional human immune system in the mouse host, cancer xenografts remain a vital tool in advancing our understanding of cancer biology and developing novel therapeutic strategies.
Topics Covered in Cancer Xenografts
Patient-Derived Models
Cell Line-Derived Models
Immunodeficient Mice
Humanized Mouse Models
Orthotopic Implantation
Drug Response Testing
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Xenografts Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Xenografts work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Xenografts research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Xenografts track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Xenografts Conference 2027 — FAQs
What is the Cancer Xenografts track at CIOC 2027?
The Cancer Xenografts track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Xenografts. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Xenografts sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Xenografts are all welcome — whether presenting or attending.
Can I present my research in the Cancer Xenografts track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Xenografts sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Xenografts track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.